Peering into gearworks of FDA
Topping off at 800 pages, “Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA” is Daniel Carpenter’s opus. Carpenter, the Allie S. Freed Professor of Government and...
View ArticleImproving a cancer drug
Harvard and Brigham and Women’s Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not...
View ArticleBetter odds
A genetic clue uncovered by Harvard researchers at Dana-Farber Cancer Institute enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukemia (T-ALL) are...
View ArticleWhen ‘watch and wait’ works best
Researchers from Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ cell ovarian tumors might be spared chemotherapy using a...
View ArticleA data bank to battle cancer
Personalized cancer treatment has become a holy grail of researchers, physicians, and patients. By reading the genes of individual tumors, drugs can sometimes be used against specific cells, replacing...
View ArticleClik here to view.
Harvard professors partner in unique approach
SAN DIEGO — In an African country lacking any specialists in children’s cancers, a team approach that “twins” Rwandan physicians with Boston-based pediatric oncologists has shown it can deliver expert,...
View ArticleSize matters in drug delivery
Combining two strategies that are designed to improve the results of cancer treatment — angiogenesis inhibitors and nanomedicines — may only be successful if the smallest nanomedicines are used. A new...
View ArticleTransforming cancer treatment
A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, “many, many cancers could be manageable.” “Many people are dying needlessly of cancer, and this...
View ArticleCatch and release
A research team at Harvard-affiliated Brigham and Women’s Hospital (BWH) has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare...
View ArticleExtra chemo could be answer
Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest...
View ArticleClik here to view.
Peering into gearworks of FDA
Topping off at 800 pages, “Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA” is Daniel Carpenter’s opus. Carpenter, the Allie S. Freed Professor of Government and...
View ArticleClik here to view.
Improving a cancer drug
Harvard and Brigham and Women’s Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not...
View ArticleClik here to view.
Better odds
A genetic clue uncovered by Harvard researchers at Dana-Farber Cancer Institute enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukemia (T-ALL) are...
View ArticleClik here to view.
When ‘watch and wait’ works best
Researchers from Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ cell ovarian tumors might be spared chemotherapy using a...
View ArticleClik here to view.
A data bank to battle cancer
Personalized cancer treatment has become a holy grail of researchers, physicians, and patients. By reading the genes of individual tumors, drugs can sometimes be used against specific cells, replacing...
View ArticleClik here to view.
Harvard professors partner in unique approach
SAN DIEGO — In an African country lacking any specialists in children’s cancers, a team approach that “twins” Rwandan physicians with Boston-based pediatric oncologists has shown it can deliver...
View ArticleClik here to view.
Size matters in drug delivery
Combining two strategies that are designed to improve the results of cancer treatment — angiogenesis inhibitors and nanomedicines — may only be successful if the smallest nanomedicines are used. A new...
View ArticleClik here to view.
Transforming cancer treatment
A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, “many, many cancers could be manageable.” “Many people are dying needlessly of cancer, and this...
View ArticleClik here to view.
Catch and release
A research team at Harvard-affiliated Brigham and Women’s Hospital (BWH) has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare...
View ArticleClik here to view.
Extra chemo could be answer
Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest...
View Article
